p53 is often inactivated in cancers by different strategies, namely by interactions with murine double minute (MDM) proteins, MDM2 and MDMX, which are commonly overexpressed in cancers or by missense mutations, leading to loss of its wild-type (wt) tumor suppressor function [6]. The gene discussed is MDM2; the disease is cancer.